Aydin Huseynov

Stock Analyst at Ladenburg Thalmann

(0.66)
# 3,978
Out of 4,964 analysts
55
Total ratings
30.61%
Success rate
-28.01%
Average return

Stocks Rated by Aydin Huseynov

Ardelyx
Mar 7, 2025
Assumes: Buy
Price Target: $11
Current: $6.19
Upside: +77.71%
UroGen Pharma
Feb 19, 2025
Assumes: Buy
Price Target: $31
Current: $19.54
Upside: +58.65%
Marker Therapeutics
Oct 21, 2024
Maintains: Buy
Price Target: $11$19
Current: $0.94
Upside: +1,921.49%
Corvus Pharmaceuticals
Sep 16, 2024
Maintains: Buy
Price Target: $12$21
Current: $5.50
Upside: +281.82%
Compass Therapeutics
Sep 16, 2024
Upgrades: Buy
Price Target: $5
Current: $3.28
Upside: +52.44%
Acrivon Therapeutics
Sep 16, 2024
Upgrades: Buy
Price Target: $16
Current: $1.37
Upside: +1,067.88%
Calidi Biotherapeutics
Jun 27, 2024
Initiates: Buy
Price Target: $120
Current: $1.67
Upside: +7,085.63%
Capricor Therapeutics
May 14, 2024
Maintains: Buy
Price Target: $24$25
Current: $6.25
Upside: +300.00%
Biodexa Pharmaceuticals
Feb 8, 2024
Initiates: Buy
Price Target: $2,000
Current: $5.71
Upside: +34,926.27%
PMV Pharmaceuticals
Dec 27, 2023
Initiates: Buy
Price Target: $7
Current: $1.43
Upside: +389.51%
Initiates: Buy
Price Target: $10
Current: $2.16
Upside: +362.96%
Initiates: Buy
Price Target: $60
Current: $13.30
Upside: +351.13%
Maintains: Buy
Price Target: $10$6
Current: $3.06
Upside: +96.08%
Maintains: Buy
Price Target: $20$10
Current: $4.98
Upside: +100.80%
Maintains: Buy
Price Target: $375$240
Current: $0.66
Upside: +36,071.82%
Maintains: Buy
Price Target: $104$182
Current: $10.76
Upside: +1,591.45%
Maintains: Speculative Buy
Price Target: $180$80
Current: $0.21
Upside: +37,476.33%
Initiates: Buy
Price Target: $20
Current: $3.04
Upside: +557.89%
Downgrades: Neutral
Price Target: n/a
Current: $5.18
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Initiates: Buy
Price Target: $6
Current: $2.65
Upside: +126.84%
Initiates: Buy
Price Target: $21
Current: $6.67
Upside: +214.84%
Initiates: Buy
Price Target: $10,500
Current: $7.38
Upside: +142,176.42%
Initiates: Buy
Price Target: $37
Current: $2.35
Upside: +1,474.47%
Upgrades: Buy
Price Target: $300
Current: $29.28
Upside: +924.59%
Downgrades: Hold
Price Target: n/a
Current: $586.96
Upside: -
Upgrades: Buy
Price Target: $89
Current: $84.84
Upside: +4.90%
Initiates: Hold
Price Target: n/a
Current: $138.13
Upside: -
Initiates: Speculative Buy
Price Target: $1,000
Current: $5.95
Upside: +16,706.72%
Initiates: Buy
Price Target: $336
Current: $2.46
Upside: +13,558.54%
Initiates: Buy
Price Target: $18
Current: $3.42
Upside: +426.32%